How is papilledema graded using the Frisén scale?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grading of Papilledema Using the Frisén Scale

Papilledema is graded using the Modified Frisén Scale, a standardized 0-5 ordinal grading system that assesses optic disc swelling severity based on specific fundoscopic features.

The Modified Frisén Scale Grades

The scale progresses from Grade 0 (normal optic disc) through Grade 5 (severe papilledema with complete obscuration of blood vessels):

  • Grade 0: Normal optic disc with clear margins and visible cup

  • Grade 1: Very early papilledema with C-shaped peripapillary halo, normal central cup, and blurring of nasal disc margin

  • Grade 2: Early papilledema with circumferential peripapillary halo, elevation of nasal disc margin, and complete obscuration of a major blood vessel as it leaves the disc

  • Grade 3: Moderate papilledema with obscuration of one or more segments of major blood vessels on the disc, elevation of the entire disc margin

  • Grade 4: Marked papilledema with elevation of the entire disc, obscuration of all vessels on the disc surface, and partial obscuration of vessel segments on the disc

  • Grade 5: Severe papilledema with dome-shaped protrusion representing at least 2 diopters of anterior protrusion, total obscuration of a segment of a major blood vessel on the disc, and peripapillary halo

Clinical Application and Documentation

All patients with papilledema should have dilated fundal examination to grade the papilledema documented at each visit 1. The consensus guidelines emphasize that formal documentation of optic nerve head appearance through serial photographs or optical coherence tomography (OCT) imaging is useful for monitoring disease progression 1.

Correlation with Objective Measures

The Frisén grading correlates well with quantitative imaging parameters. Machine learning analysis of fundus photographs demonstrates strong correlation with expert-determined Frisén grades (r=0.76, p<0.001) and can detect treatment effects over time 2. Ultrasonographic optic nerve sheath diameter shows significant correlation with Frisén grades, with mean diameter increasing progressively from lower to higher grades (p<0.001) 3.

OCT parameters including peripapillary retinal nerve fiber layer thickness, total retinal thickness, and optic nerve head volume all correlate with papilledema severity and can help differentiate true papilledema from pseudopapilledema, particularly when longitudinal changes are assessed 4.

Important Clinical Caveats

  • Inter-observer variability exists: Even experienced graders may differ by ±1 grade, which is considered acceptable agreement 2

  • Mild papilledema (Grades 1-2) can be challenging: These cases benefit most from ancillary testing with OCT and serial imaging to confirm progression 4

  • Atrophic papilledema: In chronic cases with optic atrophy, the disc appearance may not reflect current intracranial pressure elevation, though imaging parameters like optic nerve sheath diameter remain elevated 3

  • Age and sex influence severity: Papilledema severity decreases with advancing age and tends to be higher in females, independent of intracranial pressure measurements 5

The Frisén scale remains the clinical standard for grading papilledema severity and should be documented at baseline and all follow-up visits to guide management decisions and assess treatment response 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.